Beacon Biosignals is a neurotechnology company that applies machine learning to EEG to produce objective, quantitative endpoints and biomarkers for biopharma clinical development, combining an FDA 510(k)-cleared at-home headband (Waveband) with clinical trial services and analytics software.
Published Oct 15, 2026
Direct side-by-side competitor comparison pages are limited for this niche. Competitor pricing is often not fully transparent for clinical vendors.
| Starting Price | Not publicly listed (enterprise/partner-led) | Not clearly published publicly (enterprise/hospital sales) | Hardware plus subscriptions; parts of pricing are published publicly |
| Primary Use Case | At-home EEG for sleep endpoints and clinical trial services | Rapid EEG in acute care for seizure/status epilepticus detection | Research, education, prototyping, and some non-regulated research studies |
| Key Capabilities | FDA-cleared at-home EEG headband (Waveband/Dreem 3S), automated sleep staging, trial operations support | Point-of-care rapid EEG deployment in hospitals; acute-care focus | Accessible EEG hardware and developer tooling; community-driven ecosystem |
| Limitations | Limited public pricing and security documentation; public naming ambiguity; limited mainstream independent reviews | Different use case from sleep endpoints; not optimized for longitudinal sleep trials | Not positioned as a regulated clinical endpoint platform; licensing and support have mixed feedback online |
—